Skip to main content
OpenTrials

Clinical trial condition

Genital Diseases, Female

Explore clinical trials studying Genital Diseases, Female. Study availability and eligibility vary by location and protocol.

7,672 public trials 1,509 recruiting studies
Refine in advanced search Browse all conditions

Genital Diseases, Female trial results

Recruiting

Study of ACE-86225106 to Treat Patients With Advanced Solid Tumors

NCT06380660

Conditions
Adnexal Diseases, BRCA1 Mutation, BRCA2 Mutation, +27 more
Locations
  • Chongqing Cancer Hospital Chongqing, Chongqing Municipality, China
  • Fujian Cancer Hospital Fuzhou, Fujian, China
  • Sun Yat-Sen University Cancer Center Guangzhou, Guangdong, China
  • Anyang Cancer Hospital Anyang, Henan, China
View all 14 locations
View Trial Details
Recruiting

Study of Pelvic Hypofractionated Radiotherapy in Endometrial Cancer

NCT04683653

Conditions
Endometrial Cancer, Endometrial Neoplasms, Female Urogenital Diseases, +10 more
Locations
  • Winship Cancer Institute, Emory University Atlanta, Georgia, United States
  • University of Illinois at Chicago (UIC) Chicago, Illinois, United States
  • University of Chicago Chicago, Illinois, United States
  • MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Recruiting

ENDOMETRIOSIS - MRI

NCT05779462

Conditions
Comparative Study, Diagnosis, Disease, +12 more
Locations
  • Service de chirurgie gynécologique Hôpital Jeanne de Flandre - CHU de LILLE Lille, France
View Trial Details
Recruiting

A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.

NCT06022029

Conditions
Bites and Stings, Bladder Cancer, Breast Diseases, +72 more
Locations
  • California Research Institute Los Angeles, California, United States
  • BRCR Global Tamarac, Florida, United States
  • Gabrail Cancer Center Research Canton, Ohio, United States
  • Ohio State University Columbus, Ohio, United States
View all 16 locations
View Trial Details
Recruiting

Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer

NCT06463028

Conditions
Adenocarcinoma, Adnexal Diseases, Carcinoma, +31 more
Locations
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • University of California, San Francisco (UCSF) San Francisco, California, United States
  • Mount Sinai Comprehensive Cancer Center Miami Beach, Florida, United States
  • Florida Cancer Specialists, North St. Petersburg, Florida, United States
View all 18 locations
View Trial Details

Related conditions